ClinVar Miner

Submissions for variant NM_005633.4(SOS1):c.3329C>G (p.Ser1110Trp)

dbSNP: rs572955351
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 5
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
GeneDx RCV000159139 SCV000209083 uncertain significance not provided 2013-05-21 criteria provided, single submitter clinical testing The S1110W missense substitution has not been published as a mutation, nor has it been reported as a benign polymorphism to our knowledge. The NHLBI ESP Exome Variant Server reports S1110W was not observed in approximately 6,500 samples from individuals of European and African American backgrounds, indicating it is not a common benign variant in these populations. S1110W is a non-conservative amino acid substitution as a polar Serine residue is replaced with a non-polar Tryptophan residue at a position that is well conserved across species. Additionally, in silico algorithms predict S1110W is a damaging change. However, the S1110W variant is not located within any known functional domain of the protein and mutations associated with Noonan syndrome have not been reported in the literature beyond codon Proline 894. Therefore, the S1110W missense change is likely a rare benign variant; however, the possibility that is a disease-causing mutation cannot be excluded. The variant is found in SOS1 panel(s).
Ambry Genetics RCV002321669 SCV002609055 uncertain significance Cardiovascular phenotype 2021-12-23 criteria provided, single submitter clinical testing The p.S1110W variant (also known as c.3329C>G), located in coding exon 20 of the SOS1 gene, results from a C to G substitution at nucleotide position 3329. The serine at codon 1110 is replaced by tryptophan, an amino acid with highly dissimilar properties. This amino acid position is conserved. In addition, the in silico prediction for this alteration is inconclusive. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear.
Genome-Nilou Lab RCV002467628 SCV002763228 uncertain significance Noonan syndrome 4 criteria provided, single submitter clinical testing
Genome-Nilou Lab RCV002467627 SCV002763229 uncertain significance Fibromatosis, gingival, 1 criteria provided, single submitter clinical testing
Labcorp Genetics (formerly Invitae), Labcorp RCV002516397 SCV003023894 likely benign RASopathy 2023-11-08 criteria provided, single submitter clinical testing

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.